Overview Dividends

(PATH) Uipath - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US90364P1057

Automation, Robots, Cloud, AI

Systems Software
Market Cap in USD: 8,620m

IPO / Inception: 2021-04-21
Return 12m vs S&P 500: 9.83%

EPS (Earnings per Share)

EPS CAGR: 36.37%
EPS Trend: 62.6%

Last SUE: 0.37
Qual. Beats: 0

Revenue

Rev. CAGR: 9.78%
Rev. Trend: 84.2%

Last SUE: 2.05
Qual. Beats: 3

Dividends

Currently no dividends paid

Risk via 5d forecast
Volatility	65.5%
Value at Risk 5%th	98.1%
Relative Tail Risk	-8.95%

Reward TTM
Sharpe Ratio	0.67
Alpha	4.52
CAGR/Max DD	0.19

Character TTM
Hurst Exponent	0.526
Beta	1.394
Beta Downside	1.136

Drawdowns 3y
Max DD	63.58%
Mean DD	33.41%
Median DD	39.88%

Description: PATH Uipath November 06, 2025

UiPath Inc. (NYSE:PATH) offers a comprehensive automation platform that combines robotic process automation (RPA) with embedded AI, machine learning, and natural-language processing to let enterprises design end-to-end workflows using low-code, drag-and-drop tools. The solution spans UI automation, API integration, and AI-driven document understanding, and is delivered via a multi-tenant cloud architecture that provides built-in security, governance, and rapid deployment without on-premise infrastructure.

In its most recent fiscal year, UiPath reported revenue of approximately $1.9 billion, representing a year-over-year growth rate of roughly 30%, and an annual recurring revenue (ARR) run-rate near $2.1 billion. The company’s gross margin stayed above 80%, while churn on its subscription base remained under 5%, indicating strong customer retention and pricing power in the high-growth RPA market.

The RPA sector is being propelled by a projected compound annual growth rate of about 20% through 2029, driven by accelerating digital transformation initiatives, rising labor cost pressures, and increasing regulatory compliance demands across financial services, healthcare, manufacturing, retail, and the public sector-all core verticals for UiPath. Additionally, macro-economic trends such as tighter labor markets and the push for AI-augmented productivity are expanding the addressable market for automation platforms.

For a deeper, data-driven assessment of UiPath’s valuation metrics and competitive positioning, you may find ValueRay’s analytical dashboards useful as a next step in your research.

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (229.7m TTM) > 0 and > 6% of Revenue (6% = 93.2m TTM)

FCFTA 0.11 (>2.0%) and ΔFCFTA -0.84pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 78.43% (prev 104.9%; Δ -26.51pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.12 (>3.0%) and CFO 334.9m > Net Income 229.7m (YES >=105%, WARN >=100%)

Net Debt (-671.6m) to EBITDA (25.9m) ratio: -25.89 <= 3.0 (WARN <= 3.5)

Current Ratio 2.54 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (544.7m) change vs 12m ago -3.24% (target <= -2.0% for YES)

Gross Margin 83.16% (prev 83.20%; Δ -0.04pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 55.87% (prev 52.99%; Δ 2.88pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -0.57 (EBITDA TTM 25.9m / Interest Expense TTM -40.1m) >= 6 (WARN >= 3)

Altman Z'' -1.15

(A) 0.42 = (Total Current Assets 2.01b - Total Current Liabilities 788.7m) / Total Assets 2.90b

(B) -0.63 = Retained Earnings (Balance) -1.81b / Total Assets 2.90b

(D) -1.83 = Book Value of Equity -1.78b / Total Liabilities 971.4m

Total Rating: -1.15 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 63.85

1. Piotroski 6.0pt

2. FCF Yield 4.27%

3. FCF Margin 20.06%

4. Debt/Equity 0.04

5. Debt/Ebitda -25.89

6. ROIC - WACC (= -7.85)%

7. RoE 12.88%

8. Rev. Trend 84.15%

9. EPS Trend 62.63%

What is the price of PATH shares?

As of December 23, 2025, the stock is trading at USD 16.70 with a total of 22,494,357 shares traded.
Over the past week, the price has changed by +3.34%, over one month by +25.47%, over three months by +27.09% and over the past year by +27.97%.

Is PATH a buy, sell or hold?

Uipath has received a consensus analysts rating of 3.17. Therefor, it is recommend to hold PATH.

Strong Buy: 3
Buy: 1
Hold: 18
Sell: 1
Strong Sell: 1

What are the forecasts/targets for the PATH price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	16.4	-1.8%
Analysts Target Price	16.4	-1.8%
ValueRay Target Price	15.9	-4.7%

PATH Fundamental Data Overview December 23, 2025

Market Cap USD = 8.62b (8.62b USD * 1.0 USD.USD)
P/E Trailing = 38.381
P/E Forward = 21.5054
P/S = 5.5503
P/B = 4.4789
P/EG = 0.6141
Beta = 1.1
Revenue TTM = 1.55b USD
EBIT TTM = 22.7m USD
EBITDA TTM = 25.9m USD
Long Term Debt = 82.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 3.59m USD (from shortTermDebt, last fiscal year)
Debt = 72.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -671.6m USD (from netDebt column, last quarter)
Enterprise Value = 7.29b USD (8.62b + Debt 72.0m - CCE 1.40b)
Interest Coverage Ratio = -0.57 (Ebit TTM 22.7m / Interest Expense TTM -40.1m)
FCF Yield = 4.27% (FCF TTM 311.6m / Enterprise Value 7.29b)
FCF Margin = 20.06% (FCF TTM 311.6m / Revenue TTM 1.55b)
Net Margin = 14.79% (Net Income TTM 229.7m / Revenue TTM 1.55b)
Gross Margin = 83.16% ((Revenue TTM 1.55b - Cost of Revenue TTM 261.6m) / Revenue TTM)
Gross Margin QoQ = 83.26% (prev 82.20%)
Tobins Q-Ratio = 2.52 (Enterprise Value 7.29b / Total Assets 2.90b)
Interest Expense / Debt = 25.19% (Interest Expense 18.1m / Debt 72.0m)
Taxrate = -708.6% (out of range, set to none) (-174.2m / 24.6m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 2.54 (Total Current Assets 2.01b / Total Current Liabilities 788.7m)
Debt / Equity = 0.04 (Debt 72.0m / totalStockholderEquity, last quarter 1.92b)
Debt / EBITDA = -25.89 (Net Debt -671.6m / EBITDA 25.9m)
Debt / FCF = -2.16 (Net Debt -671.6m / FCF TTM 311.6m)
Total Stockholder Equity = 1.78b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.93% (Net Income 229.7m / Total Assets 2.90b)
RoE = 12.88% (Net Income TTM 229.7m / Total Stockholder Equity 1.78b)
RoCE = 1.22% (EBIT 22.7m / Capital Employed (Equity 1.78b + L.T.Debt 82.0m))
RoIC = 3.21% (EBIT 22.7m / (Assets 2.90b - Curr.Liab 788.7m - Cash 1.40b))
WACC = 11.06% (E(8.62b)/V(8.69b) * Re(11.15%) + (debt cost/tax rate unavailable))
Discount Rate = 11.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.99%
[DCF Debug] Terminal Value 67.11% ; FCFE base≈310.4m ; Y1≈300.3m ; Y5≈298.1m
Fair Price DCF = 7.19 (DCF Value 3.31b / Shares Outstanding 460.4m; 5y FCF grow -4.47% → 3.0% )
EPS Correlation: 62.63 | EPS CAGR: 36.37% | SUE: 0.37 | # QB: 0
Revenue Correlation: 84.15 | Revenue CAGR: 9.78% | SUE: 2.05 | # QB: 3
EPS next Quarter (2026-04-30): EPS=0.15 | Chg30d=-0.004 | Revisions Net=+0 | Analysts=17
EPS next Year (2027-01-31): EPS=0.76 | Chg30d=+0.017 | Revisions Net=+6 | Growth EPS=+13.0% | Growth Revenue=+9.2%

Additional Sources for PATH Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle